Nanomedicine for cancer therapy: from chemotherapeutic to hyperthermia-based therapy

This Brief focuses on the cancer therapy available till date, from conventional drug delivery to nanomedicine in clinical trial. In addition, it reports on future generation based nanotherapeutics and cancer theranostic agent for effective therapeutic diagnosis and treatment. Breast cancer was chose...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Piyush, Srivastava, Rohit
Lenguaje:eng
Publicado: Springer 2017
Materias:
Engineering
Acceso en línea:https://dx.doi.org/10.1007/978-3-319-45826-7
http://cds.cern.ch/record/2240450
_version_ 1780953053403283456
author Kumar, Piyush
Srivastava, Rohit
author_facet Kumar, Piyush
Srivastava, Rohit
author_sort Kumar, Piyush
collection CERN
description This Brief focuses on the cancer therapy available till date, from conventional drug delivery to nanomedicine in clinical trial. In addition, it reports on future generation based nanotherapeutics and cancer theranostic agent for effective therapeutic diagnosis and treatment. Breast cancer was chosen as the model system in this review. The authors give emphasis to multiple drug resistance (MDR) and its mechanism and how to overcome it using the nanoparticle approach. .
id cern-2240450
institution Organización Europea para la Investigación Nuclear
language eng
publishDate 2017
publisher Springer
record_format invenio
spelling cern-22404502021-04-21T19:24:08Zdoi:10.1007/978-3-319-45826-7http://cds.cern.ch/record/2240450engKumar, PiyushSrivastava, RohitNanomedicine for cancer therapy: from chemotherapeutic to hyperthermia-based therapyEngineeringThis Brief focuses on the cancer therapy available till date, from conventional drug delivery to nanomedicine in clinical trial. In addition, it reports on future generation based nanotherapeutics and cancer theranostic agent for effective therapeutic diagnosis and treatment. Breast cancer was chosen as the model system in this review. The authors give emphasis to multiple drug resistance (MDR) and its mechanism and how to overcome it using the nanoparticle approach. .Springeroai:cds.cern.ch:22404502017
spellingShingle Engineering
Kumar, Piyush
Srivastava, Rohit
Nanomedicine for cancer therapy: from chemotherapeutic to hyperthermia-based therapy
title Nanomedicine for cancer therapy: from chemotherapeutic to hyperthermia-based therapy
title_full Nanomedicine for cancer therapy: from chemotherapeutic to hyperthermia-based therapy
title_fullStr Nanomedicine for cancer therapy: from chemotherapeutic to hyperthermia-based therapy
title_full_unstemmed Nanomedicine for cancer therapy: from chemotherapeutic to hyperthermia-based therapy
title_short Nanomedicine for cancer therapy: from chemotherapeutic to hyperthermia-based therapy
title_sort nanomedicine for cancer therapy: from chemotherapeutic to hyperthermia-based therapy
topic Engineering
url https://dx.doi.org/10.1007/978-3-319-45826-7
http://cds.cern.ch/record/2240450
work_keys_str_mv AT kumarpiyush nanomedicineforcancertherapyfromchemotherapeutictohyperthermiabasedtherapy
AT srivastavarohit nanomedicineforcancertherapyfromchemotherapeutictohyperthermiabasedtherapy

Ejemplares similares